SULFAIR-15 Drug Patent Profile
When do Sulfair-15 patents expire, and when can generic versions of Sulfair-15 launch?
Sulfair-15 is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in SULFAIR-15 is sulfacetamide sodium. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfair-15
A generic version of SULFAIR-15 was approved as sulfacetamide sodium by CHARTWELL RX on October 18th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SULFAIR-15?
- What are the global sales for SULFAIR-15?
- What is Average Wholesale Price for SULFAIR-15?
Summary for SULFAIR-15
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 1,133 |
| DailyMed Link: | SULFAIR-15 at DailyMed |
US Patents and Regulatory Information for SULFAIR-15
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | SULFAIR-15 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 088186-001 | May 25, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
SULFAIR-15 Market Dynamics and Financial Trajectory: Pricing, Volume, Exclusivity, and Competitive Erosion
More… ↓
